Tizanidine Hydrochloride
- Product NDC
- 46708-492
- 11-digit product format
- 467080492
- Labeler code
- 46708
- Product ID
- 46708-492_cf7c5bb7-d94b-4c98-a4a2-e6a917e4165b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Limited
- Application
- ANDA213223
- Marketing category
- ANDA
- Marketing start
- 2020-01-15
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tizanidine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 485484, 485485, 485486 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 46708-492-08 | 2023-02-01 | C162847 | 48780-1 | f386c649-b1b3-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use TIZANIDINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for TIZANIDINE HYDROCHLORIDE CAPSULES. TIZANIDINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 1996 |
| 46708-492-30 | 2023-02-01 | C162847 | 48780-1 | f386c649-b1b3-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use TIZANIDINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for TIZANIDINE HYDROCHLORIDE CAPSULES. TIZANIDINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 1996 |
| 46708-492-41 | 2023-02-01 | C162847 | 48780-1 | f386c649-b1b3-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use TIZANIDINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for TIZANIDINE HYDROCHLORIDE CAPSULES. TIZANIDINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 1996 |
| 46708-492-91 | 2023-02-01 | C162847 | 48780-1 | f386c649-b1b3-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use TIZANIDINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for TIZANIDINE HYDROCHLORIDE CAPSULES. TIZANIDINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 1996 |
| 46708-492-08 | 2023-01-30 | C162847 | 48780-1 | f386c649-b1b3-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use TIZANIDINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for TIZANIDINE HYDROCHLORIDE CAPSULES. TIZANIDINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 1996 |
| 46708-492-30 | 2023-01-30 | C162847 | 48780-1 | f386c649-b1b3-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use TIZANIDINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for TIZANIDINE HYDROCHLORIDE CAPSULES. TIZANIDINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 1996 |
| 46708-492-41 | 2023-01-30 | C162847 | 48780-1 | f386c649-b1b3-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use TIZANIDINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for TIZANIDINE HYDROCHLORIDE CAPSULES. TIZANIDINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 1996 |
| 46708-492-91 | 2023-01-30 | C162847 | 48780-1 | f386c649-b1b3-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use TIZANIDINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for TIZANIDINE HYDROCHLORIDE CAPSULES. TIZANIDINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 1996 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 46708-492-08 | Tizanidine Hydrochloride | 8 in 1 BLISTER PACK | CAPSULE | 8 | | 2 |
| 46708-492-08 | Tizanidine Hydrochloride | 80 in 1 CARTON | CAPSULE | 80 | | 2 |
| 46708-492-30 | Tizanidine Hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | | 2 |
| 46708-492-41 | Tizanidine Hydrochloride | 150 in 1 BOTTLE | CAPSULE | 150 | | 2 |
| 46708-492-91 | Tizanidine Hydrochloride | 1000 in 1 BOTTLE | CAPSULE | 1000 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 46708-492 | TIZANIDINE HYDROCHLORIDE CAPSULE [ALEMBIC PHARMACEUTICALS LIMITED] | 2 | Current NDC, Legacy NDC, 5 package rows | 20230202_29750221-497e-4747-a9b8-12a0c2236eae.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 46708-492-08 | 46708049208 | 80 BLISTER PACK in 1 CARTON (46708-492-08) / 8 CAPSULE in 1 BLISTER PACK | 80 blister pack | 2020-01-15 | 0000-00-00 | No | No | Current |
| 46708-492-30 | 46708049230 | 30 CAPSULE in 1 BOTTLE (46708-492-30) | 30 capsule | 2020-01-15 | 0000-00-00 | No | No | Current |
| 46708-492-41 | 46708049241 | 150 CAPSULE in 1 BOTTLE (46708-492-41) | 150 capsule | 2020-01-15 | 0000-00-00 | No | No | Current |
| 46708-492-91 | 46708049291 | 1000 CAPSULE in 1 BOTTLE (46708-492-91) | 1000 capsule | 2020-01-15 | 0000-00-00 | No | No | Current |